FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to drugs presented in the form of an ointment, and can find application in treating atopic dermatitis. The pharmaceutical composition contains 0.05-0.10 wt % of glutamic acid dipeptide and excipients. In addition, the composition contains 1.0-10.0 wt % of glycyrrhizic acid in the form of trisodium or triammonium salt. As a dipeptide, it contains sodium salt of the dipeptide specified in a group consisting of alpha-glutamyltryptophane and lysyl-glutamine.
EFFECT: provided higher efficacy in treating atopic dermatitis ensured by relieving itching.
5 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF VIRAL DISEASES | 2010 |
|
RU2438694C1 |
| ANTI-INFLAMMATORY AND ANTI-ITCHING CREAM FOR TREATMENT OF DERMATOLOGICAL DISEASE | 2002 |
|
RU2233152C1 |
| EXTERNAL THERAPEUTIC AGENT FOR PATIENTS SUFFERING ATOPIC DERMATITIS | 2012 |
|
RU2496476C1 |
| PROANTHOCYANIDIN-CONTAINING TOPICAL PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF DERMATITIS | 2003 |
|
RU2320362C2 |
| CALCIUM GLUCONATE NANOSUBSTANCE OINTMENT FOR TREATING SKIN DISEASES RELATED TO CALCIUM DEFICIENCY | 2012 |
|
RU2506071C1 |
| MEDICAL AND COSMETIC MEANS FOR PATIENTS WITH ATOPIC DERMATITIS | 2017 |
|
RU2666220C1 |
| NEMOLIZUMAB IN TREATMENT OF ATOPIC DERMATITIS WITH MODERATE TO SEVERE EXCORIATION | 2019 |
|
RU2758378C1 |
| EXTERNAL THERAPEUTIC AGENT FOR PATIENTS SUFFERING FROM ATOPIC DERMATITIS | 2013 |
|
RU2517520C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING ATOPIC DERMATITIS AND METHOD FOR PREPARING IT | 2013 |
|
RU2538680C2 |
| COMPOSITION FOR ATOPIC DERMATITIS THERAPY BASED ON FULLEREN | 2016 |
|
RU2641041C1 |
